[ad_1]
Growing potential for autologous PRP to address the unmet need for tissue repair strategies and regenerative medicine to pave the way for new therapies for musculoskeletal and spinal disorders
Advances in Extraction of Highly Concentrated Platelets to Improve Clinical Efficacy of PRP in Orthopedic Surgery
ALBANY, NY, September 8, 2021 / PRNewswire / – Market research on transparency: Clinical recommendations for the use of platelet rich plasma (PRP) in various regenerative therapies have developed considerably, especially for tissue regeneration. PRP-derived products are emerging as a promising treatment for musculoskeletal diseases, spinal injuries, cosmetic surgeries and pain management, propelling investment in the platelet rich plasma market. The evaluation of autologous platelet-rich plasma has generated considerable interest among industry players engaged in orthopedic and stem cell research.
Advances in preparation techniques have led to the advent of PRP injections which show clinical efficacy in complex chronic wound healing, skin care therapies and musculoskeletal medicine. In the near future, large clinical trials will establish the clinical outcomes of growth factors derived from platelet-rich plasma and significantly shape the market structure, notes a study on the platelet-rich plasma market. The global market is expected to reach US $ 811.34 million by 2030.
In recent months, convalescent plasma therapy has gained popularity in the treatment of COVID-19 patients. However, its use is limited to certain subsets of patients. In addition, the rapid administration of COVID-19 vaccines in various countries has weakened R&D on these therapies. Nevertheless, ongoing randomized controlled trials (RCTs) will explore the specific role of convalescent plasma therapy in the management of COVID-like epidemics in the near future.
Strong expertise and attention to detail make our market research reports stand out, request a sample report here – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4021
Key Findings of the Platelet Rich Plasma Market Research
-
Various medical applications of PRP-derived products support huge revenue potential: The growing clinical potential of platelet rich plasma in tissue repair strategies has significantly broadened its application in the medical sector. Technological advances in the preparation of PRP-derived products have led to the clinical acceptance of PRP bioformulations. A number of clinical trials and preclinical studies have established the therapeutic potential of PRP formulations in the treatment of skeletal muscle disorders, pain management and osteoarthritis. In particular, autologous PRP research has attracted massive investment from pharmaceutical companies, enriching revenue streams in the platelet rich plasma market. Thus, industry players are evaluating the PRP mechanism in the intra-articular treatment of osteoarthritis of the knee.
-
New formulations of PRP for skin care and androgenetic alopecia will provide additional opportunities: The global prevalence of androgenetic alopecia (AGA) is a key factor in the growing number of effective therapies for its treatment, propelling PRP products to the fore. Two key factors have sparked interest in RRP growth factors, namely minimal invasiveness and lower cost than hair restoration surgeries.
-
Request for Analysis of Impact of COVID-19 on Platelet Rich Plasma Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=4021
-
Product preparation standardization protocols to shape future revenue generation: Over the years, the lack of standardization protocols for product preparation and the poor characterization of platelet-derived products in various key markets have garnered considerable attention from regulators and businesses. They are making a concerted effort to develop PRP formulations that incorporate better models of PRP preparation during clinical trial phases. The focus will be on building consensus on standardized PRP formulations and improving the safety and efficacy of end products.
Platelet Rich Plasma Market: Engines
-
The prevalence of chronic disease and the increasing incidence of chronic injuries around the world have fueled research into biological PRP treatments
-
The rise of medical tourism, particularly in emerging economies, and increasing public funding in developed economies to address unmet medical needs for tissue repair therapies in various patient populations have enriched the market value chain. plasma rich in plasma
-
Growing Number of Product Approvals in Platelet Rich Plasma Therapies Drives Demand in Platelet Rich Plasma Market
TMR offers custom market research services that help clients gain insight into their required business scenario when syndicated solutions are not enough, request custom research here – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=4021
Platelet-rich plasma market: regional growth dynamic
-
North America held a significant share of the global market in 2019. The market importance in the region can be attributed to the wide adoption of cosmetic surgeries, large clinical trials in orthobiology and the increase of RRP applications in treatment plans in medicine regenerative.
-
Opportunities for market players in Asia Pacific are expected to increase rapidly during the forecast period. The broadening of the target patient base has fueled the indications for RRP therapies, thus propelling the Asia Pacific platelet rich plasma market.
Platelet Rich Plasma Market: Key Players
Some of the major players in the platelet rich plasma market are DePuy Synthes Companies, Zimmer Biomet Holdings, Inc., ISTO Biologics, EmCyte Corporation and Arthrex, Inc.
Global Platelet Rich Plasma Market: Segmentation
-
Platelet Rich Plasma Market, By Type
-
Platelet Rich Plasma Market, By Origin
-
Platelet Rich Plasma Market, By Application
-
Platelet Rich Plasma Market, By Region
The modernization of healthcare in terms of infrastructure and services has pushed the healthcare industry to new heights, Stay up to date with Latest research reports on the health industry through the market study on transparency:
Clinical Trials Market: The clinical trials market is expected to grow at a modest CAGR of ~ 5% during the forecast period. This is evident as stakeholders face challenges related to site management and compliance in order to improve test results.
Stem Cell Market: A significant increase in the number of clinical applications of stem cells and the advent of new treatments for chronic diseases are expected to enhance the growth of the global stem cell market over the coming years. In addition to this, the increasing investment by public and private organizations for research activities is likely to complement the overall growth of the market in the near future.
Medical tourism market: According to the latest Transparency Market Research report on the global medical tourism market for the historical period 2017-2018 and forecast period 2019-2027, low cost medical treatment, availability of latest medical technologies and Wider treatment options are expected to boost the global medical tourism market.
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our proprietary blend of quantitative forecasting and trend analysis provides forward-looking information to thousands of decision makers. Our experienced team of analysts, researchers and consultants use proprietary data sources and various tools and techniques to collect and analyze information.
Our data repository is continually updated and reviewed by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analytical capacity, Transparency Market Research uses rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact us:
Sir. Rohit Bhisey
Market research on transparency
State Tower,
90 State Street,
Office 700,
Albany NY – 12207
United States
United States – Canada Toll Free: 866-552-3453
E-mail: [email protected]
Follow us: Twitter | LinkedIn
Blog: https://tmrblog.com
Browse public relations – https://www.transparencymarketresearch.com/pressrelease/platelet-rich-plasma-market.html
View original content: https://www.prnewswire.com/news-releases/continuous-rd-to-expand-therapeutic-use-of-platelet-rich-plasma-prp-in-regenerative-therapies-offer-profitable – opportunities-of-players-in-the-platelet-rich-plasma-market-market-assessment-to-reach-us-811-34-mn-by-2030-tmr -st-301371268.html
SOURCE Transparency Market Research
[ad_2]
Source link
